Dapagliflozin Raw Powder API CAS No: 960404-48-2
Dapagliflozin Raw Powder API CAS No: 960404-48-2
Dapagliflozin,960404-48-2,Dapagliflozin Raw Powder API CAS No: 960404-48-2,Dapagliflozin Raw Powder API,CAS No: 960404-48-2
Product Name: Dapagliflozin Raw API Powder
Product Purity: ≥99.0%
CAS No：960404-48-2
Send Inquiry
Description
Dapagliflozin Raw Powder API
Premium SGLT2 Inhibitor | High-Purity Pharmaceutical Grade
Storage Guidance:
Store at -20°C for long-term stability. Stock solutions should be kept at -80°C to maintain maximum potency for research applications.
Store at -20°C for long-term stability. Stock solutions should be kept at -80°C to maintain maximum potency for research applications.
Product Description
Dapagliflozin is a highly selective Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor. This high-purity API is a C-glycosyl compound characterized by its glucose sugar unit linked to an ethoxybenzyl-chlorobenzene moiety. Produced under rigorous quality standards, it is optimized for oral solid dosage formulations (tablets/capsules).
| CAS Number | 960404-48-2 |
| Molecular Formula | C₂₁H₂₅ClO₆ |
| Molecular Weight | 408.87 g/mol |
| EINECS No. | 811-335-4 |
| Appearance | White to off-white crystalline powder |
| Standard Pack | 1KG/Foil Bag; 25KG/Drum |
| Shelf Life | 24 Months |
Core Advantages
Insulin-Independent
Works via the renal glucose excretion pathway, remaining effective regardless of the patient's insulin resistance levels.
Industrial Stability
The crystalline form ensures consistent flow properties and optimal solubility during industrial tableting and encapsulation.
Global Compliance
Minimized impurity profile (Purity ≥99.0%) ensures maximum safety for finished drug product manufacturing.
Mechanism of Action
Dapagliflozin provides multi-organ therapeutic benefits through three core functions:
1. Glucose Regulation: Inhibits SGLT2 in renal tubules, reducing reabsorption and increasing urinary glucose excretion.
2. Cardio-Renal Protection: Reduces cardiac workload and intraglomerular pressure, aiding Heart Failure and CKD management.
3. Osmotic Diuresis: Assists in blood pressure reduction by reducing intravascular volume through glucose-driven diuresis.
Technical Support & FAQ
What is the purity standard for this API?
Every batch of our Dapagliflozin API is tested via HPLC to ensure a minimum purity of 99.0%, meeting international pharmaceutical standards.
Which formulations is this API suitable for?
It is specifically optimized for oral solid dosage forms, including tablets and capsules, due to its excellent crystalline stability.
Do you provide technical documentation?
Yes, Shaanxi Sunrise Pharmaceutical provides full COA (Certificate of Analysis) and MSDS for every shipment to support your regulatory requirements.
⚠ Safety Warning & Declaration
This product is a chemical raw material intended for professional laboratory research or pharmaceutical manufacturing only. It is not for direct human consumption. Shaanxi Sunrise Pharmaceutical Co., Ltd. assumes no liability for improper handling.